CoChat

Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.

Open access
Huang, Hui, Yu, Ming, Akie, Thomas E., Moran, Tyler B., Woo, Andrew J., Tu, Nathan, Waldon, Zachary, Lin, Yin Yin, Steen, Hanno, Cantor, Alan B. · 2009 · Molecular and Cellular Biology

The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index; 10 of the 32 sources its claims cite were checked for support.

Abstract

The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia. In this study, we purified RUNX-1-containing multiprotein complexes from phorbol ester-induced L8057 murine megakaryoblastic cells and identified the ets transcription factor FLI-1 as a novel in vivo-associated factor. The interaction occurs via direct protein-protein interactions and results in synergistic transcriptional activation of the c-mpl promoter. Interestingly, the interaction fails to occur in uninduced cells. Gel filtration chromatography confirms the differentiation-dependent binding and shows that it correlates with the assembly of a complex also containing the key megakaryocyte transcription factors GATA-1 and Friend of GATA-1 (FOG-1). Phosphorylation analysis of FLI-1 with uninduced versus induced L8057 cells suggests the loss of phosphorylation at serine 10 in the induced state. Substitution of Ser10 with the phosphorylation mimic aspartic acid selectively impairs RUNX-1 binding, abrogates transcriptional synergy with RUNX-1, and dominantly inhibits primary fetal liver megakaryocyte differentiation in vitro. Conversely, substitution with alanine, which blocks phosphorylation, augments differentiation of primary megakaryocytes. We propose that dephosphorylation of FLI-1 is a key event in the transcriptional regulation of megakaryocyte maturation. These findings have implications for other cell types where interactions between runx and ets family proteins occur.

Overview

CoChat Summary

TL;DR

This paper identifies FLI-1 as a novel direct RUNX-1 binding partner in megakaryocytic cells and shows that their differentiation-dependent interaction synergistically activates megakaryocyte gene transcription. It proposes that dephosphorylation of FLI-1 at Ser10 during terminal maturation promotes RUNX-1–FLI-1 complex assembly and megakaryocyte differentiation.

Key findings

  • RUNX-1 multiprotein complexes purified from TPA-induced L8057 murine megakaryoblastic cells contained FLI-1; the interaction was direct by GST pulldown and occurred via protein-protein contacts rather than DNA/RNA-linked intermediates.
  • RUNX-1/CBF-β plus FLI-1 synergistically activated the c-mpl promoter reporter: 31.2-fold over vector alone versus 2.2-fold for RUNX-1/CBF-β alone and 9.6-fold for FLI-1 alone; with GATA-1/FOG-1 included, activity was 75-fold versus 11.9-fold and 17.7-fold, respectively.
  • The interaction was differentiation-dependent: little RUNX-1–FLI-1 binding occurred in uninduced L8057 cells, while TPA induction produced a large >669 kDa complex containing RUNX-1, FLI-1, GATA-1, and FOG-1.
  • MS detected FLI-1 phosphorylation at seven sites in uninduced cells (Ser10, Ser13, Thr35, Ser37, Ser39, Ser79, Ser241) but only six in induced cells, with loss of Ser10; FLI-1S10D impaired RUNX-1 binding and abrogated transcriptional synergy, while FLI-1S10A enhanced primary megakaryocyte differentiation (CD41+/CD42b+ cells greater than wild type, P < 0.02) and FLI-1S10D inhibited it (P < 0.01).

Methods

  • Tandem FLAG–streptavidin affinity purification of biotin-tagged RUNX-1 from TPA-induced L8057 cells followed by LC-MS/MS; validation by co-IP, GST pulldown, and domain mapping in 293T/COS-7 cells.
  • Gel filtration chromatography, 2-D gel electrophoresis, and MS phosphorylation analysis; luciferase reporter assays using the murine c-mpl promoter; ChIP in induced L8057 cells and primary murine fetal liver megakaryocytes.
  • Retroviral overexpression of wild-type, S10A, or S10D FLI-1 in E13.5 fetal liver megakaryocyte precursors cultured with TPO, with flow cytometric assessment of CD41/CD42b coexpression.

Limitations

  • The paper states that it cannot exclude effects of the Ser10 mutations unrelated to phosphorylation or RUNX-1 binding; it also notes insufficient cells to confirm equivalent protein expression of the different constructs, and that the mechanism by which Ser10 phosphorylation inhibits RUNX-1 binding, as well as the responsible kinase(s)/phosphatase(s), remains unclear.
  • The paper states that it cannot conclude that loss of RUNX-1–FLI-1 interaction causes abnormal hematopoiesis in patients with the tested RUNX-1 mutations.
  • Evident from the text: several interaction-mapping inputs were not visualized by Western blotting, and key biochemical assays used heterologous cells or the L8057 cell line; the primary megakaryocyte differentiation experiments relied on retroviral overexpression rather than endogenous FLI-1 mutation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/mcb.00090-09

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 0 Not valid · 9 Not checked · 73 Own results and interpretations

51 more claims

Create a free account to see all 90 claims and to verify the 22 references still open.

See all claims — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 24

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 87

Metadata

Authors
Huang, H., Yu, M., Akie, T. E., Moran, T. B., Woo, A. J., Tu, N., Waldon, Z., Lin, Y. Y., Steen, H., & Cantor, A. B.
Affiliations
Boston Children's Hospital (US)
Corresponding author
Cantor, Alan B.
Venue
Molecular and Cellular Biology
Published
2009-08-01
Volume
29
Issue
15
Pages
4103-4115
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2103532641
Cited by
87
References
67
Citations by year
2026: 4 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 11 · 2017: 6 · 2016: 5 · 2015: 8 · 2014: 7 · 2013: 4 · 2012: 10
FWCI
5.98
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Funders
  • American Society of Hematology
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL082952)
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
FLI1, megakaryopoiesis, protein-protein interaction, transcriptional synergy, GATA-1, FOG-1, dephosphorylation, transcriptional regulation, myelodysplastic syndrome, leukemia
MeSH terms
Animals, Cell Differentiation, Cell Line, Cells, Cultured, Electrophoresis, Polyacrylamide Gel, Humans, Liver, Megakaryocytes, Mice, Inbred C57BL, Models, Biological, Mutation, Phosphorylation, Protein Binding, Serine, Tetradecanoylphorbol Acetate, Gene Expression, Protein Interaction Mapping, Core Binding Factor Alpha 2 Subunit, Mice, Proto-Oncogene Protein c-fli-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.